Detalhe da pesquisa
1.
Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(11): 1267-1275, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351334
2.
Pediatric Hodgkin Lymphoma, Version 3.2021.
J Natl Compr Canc Netw
; 19(6): 733-754, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214968
3.
Addition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival.
J Pediatr Hematol Oncol
; 41(3): e171-e173, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668545
4.
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.
Blood Adv
; 7(13): 3225-3231, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897253
5.
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.
Blood Adv
; 6(2): 452-459, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670275